Sacral nerve stimulation (SNS) is a medical electrical stimulation therapy that is used to treat long-term bowel control and bladder control symptoms through the modulation of nerves controlling the lower urinary tract and pelvic floor.
The external SNS device is one of the fastest growing product segments in the global sacral nerve stimulation market. Although there is just one external device available in the market, it is FDA approved and has the CE mark. However, this device is completely new to the market in APAC as implantable SNS devices are more popular compared with external SNS devices. With the introduction of new SNS devices by companies such as Nuvectra and Axonics Modulation Technologies, this segment is anticipated to have a positive outlook in the coming years.
Market Analysis and Insights: Global Sacral Nerve Stimulation Market
The global Sacral Nerve Stimulation market size is projected to reach US$ 765.6 million by 2026, from US$ 684.5 million in 2020, at a CAGR of 11.0%% during 2021-2026.
Global Sacral Nerve Stimulation Scope and Market Size
Sacral Nerve Stimulation market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sacral Nerve Stimulation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Medtronic
Boston Scientific
Abbott
Axonics Modulation Technologies
Nuvectra
Cogentix Medical
Cyberonics
Uroplasty, Inc
Neuropace
IntraPace, Inc
Codman & Shurtleff, Inc
Sacral Nerve Stimulation Breakdown Data by Type
Implantable SNS
External SNS
Sacral Nerve Stimulation Breakdown Data by Application
Hospitals
Clinics
ASCs
The external SNS device is one of the fastest growing product segments in the global sacral nerve stimulation market. Although there is just one external device available in the market, it is FDA approved and has the CE mark. However, this device is completely new to the market in APAC as implantable SNS devices are more popular compared with external SNS devices. With the introduction of new SNS devices by companies such as Nuvectra and Axonics Modulation Technologies, this segment is anticipated to have a positive outlook in the coming years.
Market Analysis and Insights: Global Sacral Nerve Stimulation Market
The global Sacral Nerve Stimulation market size is projected to reach US$ 765.6 million by 2026, from US$ 684.5 million in 2020, at a CAGR of 11.0%% during 2021-2026.
Global Sacral Nerve Stimulation Scope and Market Size
Sacral Nerve Stimulation market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sacral Nerve Stimulation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Medtronic
Boston Scientific
Abbott
Axonics Modulation Technologies
Nuvectra
Cogentix Medical
Cyberonics
Uroplasty, Inc
Neuropace
IntraPace, Inc
Codman & Shurtleff, Inc
Sacral Nerve Stimulation Breakdown Data by Type
Implantable SNS
External SNS
Sacral Nerve Stimulation Breakdown Data by Application
Hospitals
Clinics
ASCs
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Sacral Nerve Stimulation Revenue
1.4 Market by Type
1.4.1 Global Sacral Nerve Stimulation Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Implantable SNS
1.4.3 External SNS
1.5 Market by Application
1.5.1 Global Sacral Nerve Stimulation Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 ASCs
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Sacral Nerve Stimulation Market Perspective (2015-2026)
2.2 Global Sacral Nerve Stimulation Growth Trends by Regions
2.2.1 Sacral Nerve Stimulation Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Sacral Nerve Stimulation Historic Market Share by Regions (2015-2020)
2.2.3 Sacral Nerve Stimulation Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Sacral Nerve Stimulation Market Growth Strategy
2.3.6 Primary Interviews with Key Sacral Nerve Stimulation Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Sacral Nerve Stimulation Players by Market Size
3.1.1 Global Top Sacral Nerve Stimulation Players by Revenue (2015-2020)
3.1.2 Global Sacral Nerve Stimulation Revenue Market Share by Players (2015-2020)
3.1.3 Global Sacral Nerve Stimulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Sacral Nerve Stimulation Market Concentration Ratio
3.2.1 Global Sacral Nerve Stimulation Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Sacral Nerve Stimulation Revenue in 2019
3.3 Sacral Nerve Stimulation Key Players Head office and Area Served
3.4 Key Players Sacral Nerve Stimulation Product Solution and Service
3.5 Date of Enter into Sacral Nerve Stimulation Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Sacral Nerve Stimulation Historic Market Size by Type (2015-2020)
4.2 Global Sacral Nerve Stimulation Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Sacral Nerve Stimulation Market Size by Application (2015-2020)
5.2 Global Sacral Nerve Stimulation Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Sacral Nerve Stimulation Market Size (2015-2020)
6.2 Sacral Nerve Stimulation Key Players in North America (2019-2020)
6.3 North America Sacral Nerve Stimulation Market Size by Type (2015-2020)
6.4 North America Sacral Nerve Stimulation Market Size by Application (2015-2020)
7 Europe
7.1 Europe Sacral Nerve Stimulation Market Size (2015-2020)
7.2 Sacral Nerve Stimulation Key Players in Europe (2019-2020)
7.3 Europe Sacral Nerve Stimulation Market Size by Type (2015-2020)
7.4 Europe Sacral Nerve Stimulation Market Size by Application (2015-2020)
8 China
8.1 China Sacral Nerve Stimulation Market Size (2015-2020)
8.2 Sacral Nerve Stimulation Key Players in China (2019-2020)
8.3 China Sacral Nerve Stimulation Market Size by Type (2015-2020)
8.4 China Sacral Nerve Stimulation Market Size by Application (2015-2020)
9 Japan
9.1 Japan Sacral Nerve Stimulation Market Size (2015-2020)
9.2 Sacral Nerve Stimulation Key Players in Japan (2019-2020)
9.3 Japan Sacral Nerve Stimulation Market Size by Type (2015-2020)
9.4 Japan Sacral Nerve Stimulation Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Sacral Nerve Stimulation Market Size (2015-2020)
10.2 Sacral Nerve Stimulation Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Sacral Nerve Stimulation Market Size by Type (2015-2020)
10.4 Southeast Asia Sacral Nerve Stimulation Market Size by Application (2015-2020)
11 India
11.1 India Sacral Nerve Stimulation Market Size (2015-2020)
11.2 Sacral Nerve Stimulation Key Players in India (2019-2020)
11.3 India Sacral Nerve Stimulation Market Size by Type (2015-2020)
11.4 India Sacral Nerve Stimulation Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Sacral Nerve Stimulation Market Size (2015-2020)
12.2 Sacral Nerve Stimulation Key Players in Central & South America (2019-2020)
12.3 Central & South America Sacral Nerve Stimulation Market Size by Type (2015-2020)
12.4 Central & South America Sacral Nerve Stimulation Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Medtronic
13.1.1 Medtronic Company Details
13.1.2 Medtronic Business Overview
13.1.3 Medtronic Sacral Nerve Stimulation Introduction
13.1.4 Medtronic Revenue in Sacral Nerve Stimulation Business (2015-2020))
13.1.5 Medtronic Recent Development
13.2 Boston Scientific
13.2.1 Boston Scientific Company Details
13.2.2 Boston Scientific Business Overview
13.2.3 Boston Scientific Sacral Nerve Stimulation Introduction
13.2.4 Boston Scientific Revenue in Sacral Nerve Stimulation Business (2015-2020)
13.2.5 Boston Scientific Recent Development
13.3 Abbott
13.3.1 Abbott Company Details
13.3.2 Abbott Business Overview
13.3.3 Abbott Sacral Nerve Stimulation Introduction
13.3.4 Abbott Revenue in Sacral Nerve Stimulation Business (2015-2020)
13.3.5 Abbott Recent Development
13.4 Axonics Modulation Technologies
13.4.1 Axonics Modulation Technologies Company Details
13.4.2 Axonics Modulation Technologies Business Overview
13.4.3 Axonics Modulation Technologies Sacral Nerve Stimulation Introduction
13.4.4 Axonics Modulation Technologies Revenue in Sacral Nerve Stimulation Business (2015-2020)
13.4.5 Axonics Modulation Technologies Recent Development
13.5 Nuvectra
13.5.1 Nuvectra Company Details
13.5.2 Nuvectra Business Overview
13.5.3 Nuvectra Sacral Nerve Stimulation Introduction
13.5.4 Nuvectra Revenue in Sacral Nerve Stimulation Business (2015-2020)
13.5.5 Nuvectra Recent Development
13.6 Cogentix Medical
13.6.1 Cogentix Medical Company Details
13.6.2 Cogentix Medical Business Overview
13.6.3 Cogentix Medical Sacral Nerve Stimulation Introduction
13.6.4 Cogentix Medical Revenue in Sacral Nerve Stimulation Business (2015-2020)
13.6.5 Cogentix Medical Recent Development
13.7 Cyberonics
13.7.1 Cyberonics Company Details
13.7.2 Cyberonics Business Overview
13.7.3 Cyberonics Sacral Nerve Stimulation Introduction
13.7.4 Cyberonics Revenue in Sacral Nerve Stimulation Business (2015-2020)
13.7.5 Cyberonics Recent Development
13.8 Uroplasty, Inc
13.8.1 Uroplasty, Inc Company Details
13.8.2 Uroplasty, Inc Business Overview
13.8.3 Uroplasty, Inc Sacral Nerve Stimulation Introduction
13.8.4 Uroplasty, Inc Revenue in Sacral Nerve Stimulation Business (2015-2020)
13.8.5 Uroplasty, Inc Recent Development
13.9 Neuropace
13.9.1 Neuropace Company Details
13.9.2 Neuropace Business Overview
13.9.3 Neuropace Sacral Nerve Stimulation Introduction
13.9.4 Neuropace Revenue in Sacral Nerve Stimulation Business (2015-2020)
13.9.5 Neuropace Recent Development
13.10 IntraPace, Inc
13.10.1 IntraPace, Inc Company Details
13.10.2 IntraPace, Inc Business Overview
13.10.3 IntraPace, Inc Sacral Nerve Stimulation Introduction
13.10.4 IntraPace, Inc Revenue in Sacral Nerve Stimulation Business (2015-2020)
13.10.5 IntraPace, Inc Recent Development
13.11 Codman & Shurtleff, Inc
10.11.1 Codman & Shurtleff, Inc Company Details
10.11.2 Codman & Shurtleff, Inc Business Overview
10.11.3 Codman & Shurtleff, Inc Sacral Nerve Stimulation Introduction
10.11.4 Codman & Shurtleff, Inc Revenue in Sacral Nerve Stimulation Business (2015-2020)
10.11.5 Codman & Shurtleff, Inc Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Sacral Nerve Stimulation Revenue
1.4 Market by Type
1.4.1 Global Sacral Nerve Stimulation Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Implantable SNS
1.4.3 External SNS
1.5 Market by Application
1.5.1 Global Sacral Nerve Stimulation Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 ASCs
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Sacral Nerve Stimulation Market Perspective (2015-2026)
2.2 Global Sacral Nerve Stimulation Growth Trends by Regions
2.2.1 Sacral Nerve Stimulation Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Sacral Nerve Stimulation Historic Market Share by Regions (2015-2020)
2.2.3 Sacral Nerve Stimulation Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Sacral Nerve Stimulation Market Growth Strategy
2.3.6 Primary Interviews with Key Sacral Nerve Stimulation Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Sacral Nerve Stimulation Players by Market Size
3.1.1 Global Top Sacral Nerve Stimulation Players by Revenue (2015-2020)
3.1.2 Global Sacral Nerve Stimulation Revenue Market Share by Players (2015-2020)
3.1.3 Global Sacral Nerve Stimulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Sacral Nerve Stimulation Market Concentration Ratio
3.2.1 Global Sacral Nerve Stimulation Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Sacral Nerve Stimulation Revenue in 2019
3.3 Sacral Nerve Stimulation Key Players Head office and Area Served
3.4 Key Players Sacral Nerve Stimulation Product Solution and Service
3.5 Date of Enter into Sacral Nerve Stimulation Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Sacral Nerve Stimulation Historic Market Size by Type (2015-2020)
4.2 Global Sacral Nerve Stimulation Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Sacral Nerve Stimulation Market Size by Application (2015-2020)
5.2 Global Sacral Nerve Stimulation Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Sacral Nerve Stimulation Market Size (2015-2020)
6.2 Sacral Nerve Stimulation Key Players in North America (2019-2020)
6.3 North America Sacral Nerve Stimulation Market Size by Type (2015-2020)
6.4 North America Sacral Nerve Stimulation Market Size by Application (2015-2020)
7 Europe
7.1 Europe Sacral Nerve Stimulation Market Size (2015-2020)
7.2 Sacral Nerve Stimulation Key Players in Europe (2019-2020)
7.3 Europe Sacral Nerve Stimulation Market Size by Type (2015-2020)
7.4 Europe Sacral Nerve Stimulation Market Size by Application (2015-2020)
8 China
8.1 China Sacral Nerve Stimulation Market Size (2015-2020)
8.2 Sacral Nerve Stimulation Key Players in China (2019-2020)
8.3 China Sacral Nerve Stimulation Market Size by Type (2015-2020)
8.4 China Sacral Nerve Stimulation Market Size by Application (2015-2020)
9 Japan
9.1 Japan Sacral Nerve Stimulation Market Size (2015-2020)
9.2 Sacral Nerve Stimulation Key Players in Japan (2019-2020)
9.3 Japan Sacral Nerve Stimulation Market Size by Type (2015-2020)
9.4 Japan Sacral Nerve Stimulation Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Sacral Nerve Stimulation Market Size (2015-2020)
10.2 Sacral Nerve Stimulation Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Sacral Nerve Stimulation Market Size by Type (2015-2020)
10.4 Southeast Asia Sacral Nerve Stimulation Market Size by Application (2015-2020)
11 India
11.1 India Sacral Nerve Stimulation Market Size (2015-2020)
11.2 Sacral Nerve Stimulation Key Players in India (2019-2020)
11.3 India Sacral Nerve Stimulation Market Size by Type (2015-2020)
11.4 India Sacral Nerve Stimulation Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Sacral Nerve Stimulation Market Size (2015-2020)
12.2 Sacral Nerve Stimulation Key Players in Central & South America (2019-2020)
12.3 Central & South America Sacral Nerve Stimulation Market Size by Type (2015-2020)
12.4 Central & South America Sacral Nerve Stimulation Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Medtronic
13.1.1 Medtronic Company Details
13.1.2 Medtronic Business Overview
13.1.3 Medtronic Sacral Nerve Stimulation Introduction
13.1.4 Medtronic Revenue in Sacral Nerve Stimulation Business (2015-2020))
13.1.5 Medtronic Recent Development
13.2 Boston Scientific
13.2.1 Boston Scientific Company Details
13.2.2 Boston Scientific Business Overview
13.2.3 Boston Scientific Sacral Nerve Stimulation Introduction
13.2.4 Boston Scientific Revenue in Sacral Nerve Stimulation Business (2015-2020)
13.2.5 Boston Scientific Recent Development
13.3 Abbott
13.3.1 Abbott Company Details
13.3.2 Abbott Business Overview
13.3.3 Abbott Sacral Nerve Stimulation Introduction
13.3.4 Abbott Revenue in Sacral Nerve Stimulation Business (2015-2020)
13.3.5 Abbott Recent Development
13.4 Axonics Modulation Technologies
13.4.1 Axonics Modulation Technologies Company Details
13.4.2 Axonics Modulation Technologies Business Overview
13.4.3 Axonics Modulation Technologies Sacral Nerve Stimulation Introduction
13.4.4 Axonics Modulation Technologies Revenue in Sacral Nerve Stimulation Business (2015-2020)
13.4.5 Axonics Modulation Technologies Recent Development
13.5 Nuvectra
13.5.1 Nuvectra Company Details
13.5.2 Nuvectra Business Overview
13.5.3 Nuvectra Sacral Nerve Stimulation Introduction
13.5.4 Nuvectra Revenue in Sacral Nerve Stimulation Business (2015-2020)
13.5.5 Nuvectra Recent Development
13.6 Cogentix Medical
13.6.1 Cogentix Medical Company Details
13.6.2 Cogentix Medical Business Overview
13.6.3 Cogentix Medical Sacral Nerve Stimulation Introduction
13.6.4 Cogentix Medical Revenue in Sacral Nerve Stimulation Business (2015-2020)
13.6.5 Cogentix Medical Recent Development
13.7 Cyberonics
13.7.1 Cyberonics Company Details
13.7.2 Cyberonics Business Overview
13.7.3 Cyberonics Sacral Nerve Stimulation Introduction
13.7.4 Cyberonics Revenue in Sacral Nerve Stimulation Business (2015-2020)
13.7.5 Cyberonics Recent Development
13.8 Uroplasty, Inc
13.8.1 Uroplasty, Inc Company Details
13.8.2 Uroplasty, Inc Business Overview
13.8.3 Uroplasty, Inc Sacral Nerve Stimulation Introduction
13.8.4 Uroplasty, Inc Revenue in Sacral Nerve Stimulation Business (2015-2020)
13.8.5 Uroplasty, Inc Recent Development
13.9 Neuropace
13.9.1 Neuropace Company Details
13.9.2 Neuropace Business Overview
13.9.3 Neuropace Sacral Nerve Stimulation Introduction
13.9.4 Neuropace Revenue in Sacral Nerve Stimulation Business (2015-2020)
13.9.5 Neuropace Recent Development
13.10 IntraPace, Inc
13.10.1 IntraPace, Inc Company Details
13.10.2 IntraPace, Inc Business Overview
13.10.3 IntraPace, Inc Sacral Nerve Stimulation Introduction
13.10.4 IntraPace, Inc Revenue in Sacral Nerve Stimulation Business (2015-2020)
13.10.5 IntraPace, Inc Recent Development
13.11 Codman & Shurtleff, Inc
10.11.1 Codman & Shurtleff, Inc Company Details
10.11.2 Codman & Shurtleff, Inc Business Overview
10.11.3 Codman & Shurtleff, Inc Sacral Nerve Stimulation Introduction
10.11.4 Codman & Shurtleff, Inc Revenue in Sacral Nerve Stimulation Business (2015-2020)
10.11.5 Codman & Shurtleff, Inc Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
